Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.

SecurityCAIAF / CA Immobilien Anlagen AG (005681046)
IndustryPrepackaged Software
Institutional Owners0
Common Shares Outstanding418,179,224 shares (as of 2018-06-30)
Related CA / CA, Inc.
12673PAC9 / CA, Inc. Bond

Institutional Stock Ownership and Shareholders()

CAIAF / CA Immobilien Anlagen AG Institutional Ownership

CA Immobilien Anlagen AG (OTC:CAIAF) has 0 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .
CA Immobilien Anlagen AG (OTC:CAIAF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Prev Value
Current Value

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

CA's Q1 Earnings and Revenues Fall Short of Expectations

2018-08-07 zacks
CA Inc. (CA - Free Report) reported first-quarter fiscal 2019 non-GAAP earnings of 54 cents per share, which missed the Zacks Consensus Estimate of 69 cents. Under ASC 605, earnings of 76 cents witnessed a year-over-year increase of 25%. On a constant currency basis, it grew 20% year over year. CA reported revenues of $938 million under ASC 606, which missed the Zacks Consensus Estimate of $1.050 billion. (13-0)

Technology And Telecom Dashboard - Update

2018-08-06 seekingalpha
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages in each industry. (29-1)

Banks, downplaying recession, foresee record US M&A lending

2018-07-20 reuters
NEW YORK (LPC) - Bank lending for US mergers and acquisitions of high-grade companies will scale new heights this year, as the voracious appetite for mega-deals persists even while credit markets turn choppy and recession talk surfaces, bankers and strategists said. (27-0)

What Will Happen When The Market Has A Down Year?

2018-07-19 seekingalpha
Global equity markets continued to advance. Last week's newsletter noted the importance of closing the week above the all-important 2750 level in the EMINI SP500 Sept contract. We knew this level was huge, considering the close below on June 29th sent the contract below our 7-week moving average and was on the cusp of losing further ground. But all tariff worries aside, all geopolitical NATO posturing aside, the equity markets continued their advance on the tailwinds of massive continued corporate buybacks. (27-1)

Why Broadcom Already Should Ditch Its Planned CA Acquisition

2018-07-18 247wallst
It is no big secret that semiconductor companies all up and down the supply chain have been and would like to keep merging into larger and stronger companies so that their future cannot be broken by just one major customer. Broadcom Inc. (NASDAQ: AVGO) was hoping to acquire Qualcomm Inc. (NASDAQ: QCOM) in a deal that faced more scrutiny and reviews than most companies would be able to stand. Now that the Qualcomm issue is believed to be behind Broadcom, the company has decided that CA Inc. (8-2)

CUSIP: 005681046